← Back
$ONC All transactions

BeOne Medicines Ltd.

A

$ Value

$0

Shares

117,936

Price

$0

Filed

Mar 10

Insider

Name

OYLER JOHN

Title

Chief Executive Officer

CIK

0001042047

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-06

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

5,609,275

Footnotes

Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested shares are subject to accelerated vesting upon change of control or certain termination events. | Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2028, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested shares are subject to accelerated vesting upon change of control or certain termination events. | These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership. | These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. | These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. | These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account. | These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.

Filing Info

Accession No.

0001042047-26-000002

Form Type

4

Issuer CIK

0001651308

OYLER JOHN's History

Date Ticker Type Value
2026-03-06 ONC A $0
2026-03-06 ONC A $0
2025-12-16 ONC $565K
2025-12-16 ONC $181K
2025-12-16 ONC $775K
2025-12-16 ONC $457K
2025-12-16 ONC $2.3M
2025-12-16 ONC $495K
2025-12-16 ONC $1.7M
2025-12-16 ONC $382K

Other Insiders at ONC (90d)

Insider Bought Sold Last
OYLER JOHN
Chief Executive Officer
2026-03-06
Wu Xiaobin
President and COO
2026-03-06
Wang Lai
President, Global Head of R&D
2026-03-06
Lee Chan Henry
SVP, General Counsel
$786K 2026-04-08
Rosenberg Aaron
Chief Financial Officer
2026-03-06